Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hope trumpets quality of first US approved sodium nitrite injection for cyanide poisoning

This article was originally published in Scrip

Executive Summary

The US FDA has approved Hope Pharmaceuticals' sodium nitrite injection for treating life-threatening cyanide poisoning. The firm says it is the first sodium nitrite injection to be FDA-approved. In a statement, Hope draws attention to the importance of high-quality medicines for very sick patients and says that doctors should choose an approved product whenever possible. Sodium nitrite drugs have been available in the US without approval for some time and conform to industry specifications published before 1970. Hope's injection, intended for sequential use with sodium thiosulphate, meets more stringent requirements, including recent advances in quality including limits on bacterial, chemical, degradation and processing impurities.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC016975

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel